Erratum: Copper and clioquinol treatment in young APP transgenic and wildtype mice: Effects on life expectancy, body weight and metal-ion levels (Journal of Molecular Medicine DOI: 10.1007/s00109-006-0140-7);Copper and clioquinol treatment in young APP transgenic and wild-type mice: Effects on life expectancy, body weight, and metal-ion levels

Journal of Molecular Medicine

Volumn 85, Issue 4, 2007, Pages 405-413

  Schäfer, Stephanie ^a   Pajonk, Frank Gerald ^a   Multhaup, Gerd ^b   Bayer, Thomas A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

APP; Clioquinol; Cu; Metal homeostasis; Transgenic mice

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CLIOQUINOL; COPPER; COPPER SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN LEVEL; BRAIN METABOLISM; COMPLEX FORMATION; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; DEGENERATIVE DISEASE; IN VIVO STUDY; IRON BLOOD LEVEL; LIFE EXPECTANCY; MINERAL INTAKE; MOUSE; NONHUMAN; NUTRITIONAL VALUE; PHARMACODYNAMICS; TRANSGENIC MOUSE; WILD TYPE; ZINC BLOOD LEVEL;

EID: 33947383715     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0171-8     Document Type: Erratum

References (30)

1. Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX (2005) Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol 86:147-159
2. Bayer TA, Multhaup G (2005) Involvement of amyloid beta precursor protein (AbetaPP) modulated copper homeostasis in Alzheimer's disease. J Alzheimer's Dis 8:201-206 (discussion 209-15)
3. Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, Beyreuther K, Masters CL, Bush AI, Li QX (2002) Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem 277:44670-44676
4. Bayer TA, Schafer S, Simons A, Kemmling A, Kamer T, Tepest R, Eckert A, Schussel K, Eikenberg O, Sturchler-Pierrat C, Abramowski D, Staufenbiel M, Multhaup G (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci USA 100:14187-14192
5. Phinney AL, Drisaldi B, Schmidt SD, Lugowski S, Coronado V, Liang Y, Horne P, Yang J, Sekoulidis J, Coomaraswamy J, Chishti MA, Cox DW, Mathews PM, Nixon RA, Carlson GA, St George-Hyslop P, Westaway D (2003) In vivo reduction of amyloid-beta by a mutant copper transporter. Proc Natl Acad Sci USA 100:14193-14198
6. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30:665-676
7. Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE, Masters CL (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60:1685-1691
8. Yassin MS, Ekblom J, Xilinas M, Gottfries CG, Oreland L (2000) Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol. J Neurol Sci 173:40-44
9. Arbiser JL, Kraeft SK, van Leeuwen R, Hurwitz SJ, Selig M, Dickersin GR, Flint A, Byers HR, Chen LB (1998) Clioquinol-zinc chelate: a candidate causative agent of subacute myelo-optic neuropathy. Mol Med 4:665-670
10. White AR, Du T, Laughton KM, Volitakis I, Sharples RA, Hoke DE, Holsinger RM, Evin G, Cherny RA, Hill AF, Barnham KJ, Li QX, Bush AI, Masters CL (2006) Degradation of the Alzheimer's disease amyloid beta peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem 281:17670-17680
11. Treiber C, Simons A, Strauss M, Hafner M, Cappai R, Bayer TA, Multhaup G (2004) Clioquinol mediates copper uptake and counteracts Cu efflux activities of the amyloid precursor protein of Alzheimer's disease. J Biol Chem 50:51958-51964
12. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D et al (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15:1203-1218
13. Laboratory TJ (1975) Biology of the laboratory mouse. Dover, New York
14. Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, Canton T, Jedidi I, Gohin M, Wirths O, Bayer TA, Langui D, Duyckaerts C, Tremp G, Pradier L (2003) Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp Neurol 184:247-263
15. Bartnikas TB, Gitlin JD (2003) Mechanisms of biosynthesis of mammalian copper/zinc superoxide dismutase. J Biol Chem 278:33602-33608
16. Yassin MS, Ekblom J, Lofberg C, Oreland L (1998) Transmethylation reactions and autoradiographic distribution of vitamin B12: effects of clioquinol treatment in mice. Jpn J Pharmacol 78:55-61
17. Nguyen T, Hamby A, Massa SM (2005) Clioquinol downregulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model. Proc Natl Acad Sci USA 102:11840-11845
18. Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boonplueang R, Viswanath V, Jacobs R, Yang L, Beal MF, DiMonte D, Volitaskis I, Ellerby L, Cherny RA, Bush AI, Andersen JK (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37:899-909
19. Ding WQ, Liu B, Vaught JL, Yamauchi H, Lind SE (2005) Anticancer activity of the antibiotic clioquinol. Cancer Res 65:3389-3395
20. Daniel KG, Chen D, Orlu S, Cui QC, Miller FR, Dou QP (2005) Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. Breast Cancer Res 7:R897-R908
21. Di Vaira M, Bazzicalupi C, Orioli P, Messori L, Bruni B, Zatta P (2004) Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes. Inorg Chem 43:3795-3797
22. Tjalve H, Stahl K (1984) Effect of 5-chloro-7-iodo-8-hydroxyquinoline (clioquinol) on the uptake and distribution of nickel, zinc and mercury in mice. Acta Pharmacol Toxicol (Copenh) 55:65-72
23. Weismann K, Knudsen L (1978) Effects of penicillamine and hydroxyquinoline on absorption of orally ingested 65zinc in the rat. J Invest Dermatol 71:242-244
24. Carlson GA, Borchelt DR, Dake A, Turner S, Danielson V, Coffin JD, Eckman C, Meiners J, Nilsen SP, Younkin SG, Hsiao KK (1997) Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum Mol Genet 6:1951-1959
25. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George-Hyslop PS, Westaway D (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276:21562-21570
26. Nitzan YB, Sekler I, Frederickson CJ, Coulter DA, Balaji RV, Liang SL, Margulis A, Hershfinkel M, Silverman WF (2003) Clioquinol effects on tissue chelatable zinc in mice. J Mol Med 81:637-644
27. Fox PL (2003) The copper-iron chronicles: the story of an intimate relationship. Biometals 16:9-40
28. Santon A, Formigari A, Albergoni V, Irato P (2006) Effect of Zn treatment on wild type and MT-null cell lines in relation to apoptotic and/or necrotic processes and on MT isoform gene expression. Biochim Biophys Acta 1763:305-312
29. Kondo Y, Rusnak JM, Hoyt DG, Settineri CE, Pitt BR, Lazo JS (1997) Enhanced apoptosis in metallothionein null cells. Mol Pharmacol 52:195-201
30. Tang ZL, Wasserloos KJ, Liu X, Stitt MS, Reynolds IJ, Pitt BR, St Croix CM (2002) Nitric oxide decreases the sensitivity of pulmonary endothelial cells to LPS-induced apoptosis in a zinc-dependent fashion. Mol Cell Biochem 21:234-235